CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 58 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2022. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | +100.0% | 4,849 | +123.5% | 0.00% | – |
| Q2 2023 | $2 | -100.0% | 2,170 | -91.1% | 0.00% | – |
| Q3 2022 | $27,000 | -28.9% | 24,458 | -7.6% | 0.00% | – |
| Q2 2022 | $38,000 | +111.1% | 26,461 | +222.8% | 0.00% | – |
| Q1 2022 | $18,000 | +12.5% | 8,197 | +36.2% | 0.00% | – |
| Q4 2021 | $16,000 | – | 6,017 | +30.8% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 4,600 | -67.2% | 0.00% | – |
| Q2 2020 | $26,000 | +4.0% | 14,004 | -7.3% | 0.00% | – |
| Q1 2020 | $25,000 | -88.6% | 15,107 | -80.1% | 0.00% | – |
| Q4 2019 | $220,000 | – | 75,870 | +16685.4% | 0.00% | – |
| Q3 2019 | $0 | – | 452 | -2.6% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 464 | -87.3% | 0.00% | – |
| Q4 2018 | $3,000 | -90.0% | 3,641 | -27.6% | 0.00% | – |
| Q3 2018 | $30,000 | -90.3% | 5,027 | -82.6% | 0.00% | -100.0% |
| Q2 2018 | $308,000 | – | 28,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 3,750,107 | $10,875,000 | 0.41% |
| Plante Moran Financial Advisors, LLC | 50,000 | $145,000 | 0.05% |
| Donald L. Hagan, LLC | 14,000 | $40,000 | 0.04% |
| Game Plan Financial Advisors, LLC | 11,000 | $32,000 | 0.03% |
| Tekla Capital Management LLC | 165,330 | $479,000 | 0.02% |
| Virtu Financial LLC | 52,655 | $153,000 | 0.02% |
| SIGNATUREFD, LLC | 58,326 | $169,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 131,783 | $382,000 | 0.01% |
| Lindbrook Capital, LLC | 10,000 | $29,000 | 0.01% |
| WEDBUSH SECURITIES INC | 40,700 | $118,000 | 0.01% |